Positions

Selected Publications

Academic Article

Year Title Altmetric
2021 Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial 2021
2021 Dystonia and Tremor: A Cross-Sectional Study of the Dystonia Coalition CohortNeurology.  96:e563-e574. 2021
2020 It's tricky: Rating alleviating maneuvers in cervical dystoniaJournal of the Neurological Sciences.  419. 2020
2019 Reducing neurodisparity: Recommendations of the 2017 AAN Diversity Leadership ProgramNeurology.  92:e274-e280. 2019
2017 Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An Analysis of NET-PD LS1Journal of Parkinson's Disease.  7:117-127. 2017
2016 Clinical and genetic features of cervical dystonia in a large multicenter cohortNeurology Genetics.  2. 2016
2015 Gastroretentive carbidopa/levodopa, DM-1992, for the treatment of advanced Parkinson's diseaseMovement Disorders.  30:1222-1228. 2015
2014 A randomized clinical trial of high-dosage coenzyme Q10 in early parkinson disease no evidence of benefitJAMA Neurology.  75:543-552. 2014
2013 Impaired financial abilities in Parkinson's disease patients with mild cognitive impairment and dementiaParkinsonism and Related Disorders.  19:986-990. 2013
2013 Multisite, double-blind, randomized, controlled study of pregabalin for essential tremorMovement Disorders.  28:249-250. 2013
2012 Reliability of a new scale for essential tremorMovement Disorders.  27:1567-1569. 2012
2009 Weight changes associated with unilateral STN DBS and advanced PDParkinsonism and Related Disorders.  15:709-711. 2009
2009 The contribution of executive control on verbal-learning impairment in patients with Parkinson's disease with dementia and Alzheimer's diseaseArchives of Clinical Neuropsychology.  24:237-244. 2009
2008 Medical decision-making capacity in cognitively impaired Parkinson's disease patients without dementiaMovement Disorders.  23:1867-1874. 2008
2008 Spheramine for Treatment of Parkinson's DiseaseNeurotherapeutics.  5:252-259. 2008
2008 A pilot clinical trial of creatine and minocycline in early parkinson disease: 18-month resultsClinical Neuropharmacology.  31:141-150. 2008
2007 A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson diseaseNeurology.  68:20-28. 2007
2007 Corticobasal degenerationHandbook of Clinical Neurology.  84:351-372. 2007
2006 A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson diseaseNeurology.  66:664-671. 2006
2005 Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson diseaseArchives of Neurology.  62:1833-1837. 2005
2005 Stimulation of the subthalamic nucleus in a patient with Parkinson disease and essential tremorArchives of Neurology.  62:141-143. 2005
2004 Implantation of Spheramine® in advanced Parkinson's Disease (PD)Frontiers in Bioscience.  9:592-602. 2004
2003 Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: A potential new cell therapy for Parkinson's disease 2003
2001 Complications of gamma knife surgery for Parkinson diseaseArchives of Neurology.  58:1995-2002. 2001
2001 Corticobasal degenerationSeminars in Neurology.  21:49-58. 2001

Principal Investigator On

  • A Multi-Site, Double-Blind, Randomized, Placebo-Controlled, Crossover Study of Pregabalin (Lyrica, PGB) in the Treatment of Essential Tremor  awarded by UNIVERSITY OF SOUTH FLORIDA
  • A Randomized Recruitment Intervention (RECRUIT)  awarded by UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER (HOUSTON)
  • A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two-Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants with Parkinson’s Disease (PD)  awarded by Northwestern University
  • American Academy of Neurology's 2019 Fellow Scholarship Annual Meeting  awarded by American Academy of Neurology
  • Clinical Coordination Center for STEADY-PD3  awarded by Northwestern University
  • Dystonia Coalition Projects-3 (DCP3)  awarded by Emory University
  • Dystonia Coalitions Projects  awarded by Emory University
  • Effects of Coenzyme Q10 in Parkinson Disease - Phase III (QE3)  awarded by Weill (Joan and Sanford I.) Medical College of Cornell University
  • Fellows Scholarship: "The Aspen Course" A Comprehensive Review of Movement Disorders for the Clinical Practitioner  awarded by INTERNATIONAL PARKINSON AND MOVEMENT DISORDER SOCIETY
  • Phase 3 Trial of Inosine for Parkinson's Disease CCC  awarded by MASSACHUSETTS GENERAL HOSPITAL
  • Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. ^
  • Private Grant  awarded by MERZ PHARMACEUTICALS
  • Private Grant  awarded by EISAI MEDICAL RESEARCH, INC.
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by PHARMACEUTICAL RESEARCH ASSOCIATES, INC
  • Private Grant  awarded by ALLERGAN SALES, LLC
  • Private Grant  awarded by IMAPX PHARMACEUTICALS
  • Private Grant  awarded by EMD SERONO
  • Private Grant  awarded by EMD SERONO
  • Private Grant  awarded by IMPAX LABORATORIES, INC.
  • Private Grant  awarded by CHELSEA THERAPEUTICS, INC.
  • Private Grant  awarded by TEVA PHARMACEUTICAL INDUSTRIES LTD
  • Private Grant  awarded by BIOTIE THERAPIES CORPORATION
  • Private Grant  awarded by EMD SERONO
  • Private Grant  awarded by EMD SERONO
  • Private Grant  awarded by IMPAX LABORATORIES, INC.
  • Private Grant  awarded by DEPOMED, INC.
  • Private Grant  awarded by MERZ PHARMACEUTICALS
  • Private Grant  awarded by IMPAX LABORATORIES, INC.
  • Private Grant  awarded by ASTRAZENECA AB
  • Private Grant  awarded by UCB BIOSCIENCES
  • Private Grant  awarded by IPSEN BIOPHARMACEUTICALS, INC.
  • Private Grant  awarded by IPSEN BIOPHARMACEUTICALS, INC.
  • Private Grant  awarded by PHARMA TWO B. LTD
  • Private Grant  awarded by BIOTIE THERAPIES CORPORATION
  • Private Grant  awarded by US WORLDMEDS, LLC
  • Private Grant  awarded by SERINA THERAPEUTICS ^
  • Private Grant  awarded by INTEC PHARMACEUTICALS, LTD
  • Private Grant  awarded by INTEC PHARMACEUTICALS, LTD
  • Private Grant  awarded by BIOGEN IDEC, INC.
  • Private Grant  awarded by NEURALY INC.
  • SYN120 a Dual 5-HT6/5-HT2A Antagonist Proof of Concept Study to Evaluate its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)  awarded by MASSACHUSETTS GENERAL HOSPITAL
  • Validation of the TRG Essential Tremor Rating Scale (TETRAS)  awarded by SOUTHERN ILLINOIS UNIVERSITY
  • Investigator On

  • Innate and Adaptive Immunity in Parkinson Disease  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS
  • Innate and Adaptive Immunity in Parkinson Disease - Core B: Clinical Research Core  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS
  • Innate and Adaptive Immunity in Parkinson Disease - Project 5: Innate and Adaptive Immunity in Lewy Body Dementia  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS
  • Private Grant  awarded by SANGAMO BIOSCIENCES, INC.
  • Private Grant  awarded by ADAMAS PHARMACEUTICALS, INC.
  • Private Grant  awarded by ADAMAS PHARMACEUTICALS, INC.
  • Private Grant  awarded by ADAMAS PHARMACEUTICALS, INC.
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd.
  • Private Grant  awarded by NEURODERM, LTD.
  • Private Grant  awarded by PRILENIA THERAPEUTICS DEVELOPMENT LTD
  • Private Grant  awarded by ABBVIE INC
  • Private Grant  awarded by CEREVEL THERAPEUTICS, LLC
  • Private Grant  awarded by ABBVIE INC
  • Private Grant  awarded by ABBVIE INC
  • Private Grant  awarded by CEREVEL THERAPEUTICS, LLC
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd.
  • UAB Bachmann-Straus Dystonia and Parkinson's Disease Center of Excellence  awarded by Bachmann-Strauss Dystonia & Parkinson Foundation, Inc
  • UAB PD Neuroprotection Clinical Trial Center  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS
  • UAB Parkinson's Disease Neuroprotection Clinical Trial Center  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS
  • Education And Training

  • Medical College of Virginia Hospital, Internship
  • Emory University Hospital Systems, Residency
  • Medical College of Virginia Hospital, Residency
  • Emory University Hospital Systems, Postdoctoral Fellowship
  • Bachelor of Medicine & Surgery (MBBS), 1985
  • Full Name

  • Natividad Stover